Increased Incidence of Gestational Diabetes in Women Receiving Prophylactic 17α-Hydroxyprogesterone Caproate for Prevention of Recurrent Preterm Delivery

200798 citationsJournal Articlebronze Open Access

Authors

Andrei Rebarber · Icahn School of Medicine at Mount Sinai

Niki Istwan

Karen Russo-Stieglitz · Valley Health System

Jane Cleary‐Goldman · Icahn School of Medicine at Mount Sinai

Debbie Rhea

Gary Stanziano

Daniel H. Saltzman · Icahn School of Medicine at Mount Sinai

Abstract

The use of 17P for the prevention of recurrent preterm delivery is associated with an increased risk of developing GDM. Early GDM screening is appropriate for women receiving 17P prophylaxis.

Topics & Keywords

Gestational Diabetes Research and Management Preterm Birth and Chorioamnionitis Pregnancy-related medical research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetes Care

Volume 30, Issue 9, pp. 2277-2280

DOI: 10.2337/dc07-0564

Field-Weighted Citation Impact: 5.10